0001950047-24-005145.txt : 20240701
0001950047-24-005145.hdr.sgml : 20240701
20240701164309
ACCESSION NUMBER: 0001950047-24-005145
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240701
DATE AS OF CHANGE: 20240701
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: 4D Molecular Therapeutics, Inc.
CENTRAL INDEX KEY: 0001650648
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473506994
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39782
FILM NUMBER: 241091298
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5105052680
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc.
DATE OF NAME CHANGE: 20200506
FORMER COMPANY:
FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc
DATE OF NAME CHANGE: 20150811
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bizily Scott
CENTRAL INDEX KEY: 0001920738
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O 4D MOLECULAR THERAPEUTICS, INC.
STREET 2: 5858 HORTON STREET #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
144
1
primary_doc.xml
144
0001920738
XXXXXXXX
LIVE
0001650648
4D Molecular Therapeutics, Inc.
001-39782
5858 Horton Street, #455
Emeryville
CA
94608
5105052680
SCOTT BIZILY
Officer
COMMON
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
9498
199363.02
51703412
07/01/2024
NASDAQ
Common
07/01/2024
Exercise of Stock Options
Issuer
N
9498
07/01/2024
Cash
N
10b5-1 Sales for SCOTT BIZILY
5858 Horton Street, #455
Emeryville
CA
94608
COMMON
06/17/2024
1750
41493.50
10b5-1 Sales for SCOTT BIZILY
5858 Horton Street, #455
Emeryville
CA
94608
COMMON
05/16/2024
1750
44541.00
10b5-1 Sales for SCOTT BIZILY
5858 Horton Street, #455
Emeryville
CA
94608
COMMON
04/16/2024
1750
45045.00
The securities to be sold were and will be received upon the exercise of stock options over the next three months.
The date of acquisition and payment was and will be the date of exercise/sale.
07/01/2024
10/10/2023
/s/ Scott Patrick Bizily